TAFI | VTES | TAFI / VTES | |
Gain YTD | 2.929 | 1.604 | 183% |
Net Assets | 857M | 1.32B | 65% |
Total Expense Ratio | 0.27 | 0.06 | 450% |
Turnover | 29.00 | 21.00 | 138% |
Yield | 3.37 | 2.87 | 117% |
Fund Existence | 3 years | 2 years | - |
TAFI | VTES | |
---|---|---|
RSI ODDS (%) | 2 days ago10% | 2 days ago5% |
Stochastic ODDS (%) | 2 days ago9% | 2 days ago13% |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | 2 days ago19% | 2 days ago11% |
TrendWeek ODDS (%) | 2 days ago18% | 2 days ago15% |
TrendMonth ODDS (%) | 2 days ago16% | 2 days ago8% |
Advances ODDS (%) | 5 days ago23% | 2 days ago14% |
Declines ODDS (%) | N/A | 8 days ago12% |
BollingerBands ODDS (%) | 2 days ago13% | 2 days ago17% |
Aroon ODDS (%) | 2 days ago14% | 2 days ago10% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RNEBX | 89.39 | 1.16 | +1.31% |
American Funds New World R2E | |||
VGSAX | 36.29 | N/A | N/A |
Virtus Duff & Phelps Glb Rl Estt Secs A | |||
RAGHX | 26.28 | N/A | N/A |
Virtus KAR Health Sciences A | |||
GSPAX | 18.05 | N/A | N/A |
Goldman Sachs US Eq Div and Premium A | |||
SMVZX | 12.62 | N/A | N/A |
Virtus Ceredex Mid-Cap Value Equity R6 |